Prescribing of anti-dementia medications in primary care: A retrospective cohort study in 1489 English General Practices
Charlotte Morris, Pearl L H Mok, Dame Louise Robinson, Louise Allan, Darren M Ashcroft, Tom Blakeman, Evangelos Kontopantelis · 2026
Read Prescribing of anti-dementia medications in primary care: A retrospective cohort study in 1489 English General Practices by Charlotte Morris, Pearl L H Mok, Dame Louise Robinson, Louise Allan, Darren M Ashcroft, Tom Blakeman, Evangelos Kontopantelis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0347921.txt.
Description
Charlotte Morris, Evangelos Kontopantelis, and co-authors examined who actually receives dementia medicines in English primary care. Drugs called cholinesterase inhibitors, plus memantine, are recommended for Alzheimer's disease and some related dementias. Their 2026 study drew on records from nearly fifteen hundred practices, covering more than two hundred forty thousand patients diagnosed between 2006 and 2024.
Only about six in ten patients ever got one of these medicines, and taking both kinds together stayed rare despite guidelines. People in the poorest areas, some ethnic minority groups, and people with learning disabilities were all less likely to be treated. The authors call the gaps unfair and urge better access, since the pattern suggests need alone is not deciding who gets help.
Catalog record
| CREATOR | Charlotte Morris, Pearl L H Mok, Dame Louise Robinson, Louise Allan, Darren M Ashcroft, Tom Blakeman, Evangelos Kontopantelis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46149 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |